Intravenous (IV) Equipment Market Outlook, 2028

Intravenous (IV) equipment plays a pivotal role in the delivery of life-saving treatments and medications directly into the bloodstream, making it an indispensable aspect of modern healthcare. The Intravenous (IV) equipment industry plays a crucial role in modern healthcare by providing essential tools for the administration of fluids, medications, and nutrients directly into the bloodstream. This industry has witnessed significant advancements in recent years, driven by technological innovations, increasing healthcare demands, and a growing emphasis on patient safety. Over the years, the IV equipment industry has undergone significant transformations driven by technological advancements, patient-centric design, and a commitment to improving safety and efficacy. As the healthcare industry increasingly embraces patient-centered care, IV equipment manufacturers are prioritizing patient comfort and mobility.

Designs that reduce noise, minimize discomfort during infusion, and allow for increased patient mobility are gaining traction. Portable infusion devices enable patients to receive treatments in various settings, promoting flexibility and independence in their healthcare journey. The IV equipment industry operates within a rigorous regulatory framework to ensure the safety and efficacy of medical devices. Adherence to standards set by regulatory bodies such as the FDA and EMA is paramount for manufacturers. Stringent quality control measures and continuous monitoring help maintain the integrity of IV equipment, safeguarding patient welfare.

Surgical procedures often necessitate the use of intravenous therapy for various purposes, including fluid replacement, anesthesia administration, and post-operative pain management. With the rising number of surgeries being performed globally, there is a corresponding increase in the demand for IV equipment.

Hospitals and healthcare facilities require a reliable supply of IV catheters, infusion pumps, and related equipment to support safe and efficient perioperative care. For instance, according to the National Library of Medicine, which is part of the National Institutes of Health (NIH) reports that globally, there are approximately 310 million major surgeries performed annually, with 40 to 50 million taking place in the U.S. and 20 million in Europe.

According to the research report, “Global Intravenous (IV) Equipment Market Outlook, 2028”, the market is anticipated to cross USD 20 Billion by 2028, increasing from USD 14.02 Billion in 2022. The market is expected to grow with more than 6.72% CAGR by 2023-28. The rising incidence of chronic diseases, mainly due to the increasing aging population, and the growing use of IV therapy in their treatment are expected to drive the growth of this market in the coming years. Increasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needle stick injuries and infections are the key factors driving the growth of this market. Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein.

They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer significant advantages over manual fluid administration, including the ability to deliver fluids in very small volumes and at precisely programmed rates or automated intervals. These devices are also used for blood transfusion. The sudden outbreak of COVID-19 had a severe impact on the intravenous (IV) equipment industry due to a sudden halt in surgical procedures that were non-immediate and were being postponed to decrease the burden on healthcare infrastructure. The use of intravenous therapies was restricted for the treatment of COVID-19 to reduce the chances of infection.

For instance, as per the guidelines published by the National Institute of Health in July 2023, it was found that the COVID-19 Treatment Guidelines Panel recommended the utilization of IV Immunoglobulin for treating acute COVID-19 infection. Therefore, with the restricted use of IV for COVID-19 treatment, there was a considerable impact on the market studied. However, currently, the market has reached its pre-pandemic nature in terms of demand for IV equipment and is expected to witness strong growth in the coming years.

The growing prevalence of chronic diseases, increasing surgical procedures in the region, and product launches by the major market players are driving the market growth of the North American region.

North America boasts a highly advanced and sophisticated healthcare infrastructure. The region is home to numerous world-class medical facilities, research institutions, and hospitals that are early adopters of the latest medical technologies, including IV equipment. The prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is relatively high in North America. Patients with these conditions often require regular intravenous therapies, driving the demand for IV equipment. The North American healthcare industry has been at the forefront of technological advancements and innovations. The region is a hub for research and development in medical devices, leading to the creation of cutting-edge IV equipment with features like smart infusion systems, connectivity, and advanced safety measures.

Governments and private organizations in North America make substantial investments in healthcare, supporting research, development, and the adoption of advanced medical technologies. This financial backing contributes to the growth and dominance of the IV equipment market in the region. North America has stringent regulatory standards, particularly set by the U.S. Food and Drug Administration (FDA). These standards ensure the safety and efficacy of medical devices, including IV equipment. Compliance with these standards enhances the credibility of products, fostering trust among healthcare professionals and end-users. The United States, in particular, has one of the highest healthcare spending levels globally. This high expenditure contributes to the adoption of advanced medical technologies, and healthcare providers are more likely to invest in state-of-the-art IV equipment to improve patient care.

The aging population in North America requires increased healthcare services, including intravenous therapies. The demographic shift toward an older population has led to a higher demand for IV equipment to manage age-related health conditions. The North American IV equipment market is highly competitive, with the presence of major players and a robust network of manufacturers. This competition drives continuous innovation and ensures a wide range of high-quality products, further solidifying the region's dominance. North America has well-established distribution channels for medical devices, facilitating the efficient supply and distribution of IV equipment. This infrastructure ensures that healthcare facilities have timely access to the latest and most advanced IV technologies.

Based on the product type, IV catheters are projected to dominate the overall market by 2028 being the essential tools to deliver IV medications, blood products, and nutritional fluids to patients.

IV catheters are indispensable for establishing intravenous access, allowing healthcare providers to administer fluids, medications, and other therapeutic agents directly into the patient's bloodstream. This fundamental role positions IV catheters as a cornerstone in the field of intravenous therapy. IV catheters find applications in a wide range of medical scenarios, from routine medical procedures to critical care situations. They are used for hydration, medication administration, blood transfusions, chemotherapy, and emergency treatments. The versatility of IV catheters contributes to their widespread adoption across various medical specialties.

Patients of all ages and medical conditions may require intravenous therapy at some point. IV catheters are designed to meet the specific needs of diverse patient populations, from neonates to elderly individuals. The adaptability of IV catheters to different patient groups further contributes to their dominance in the IV equipment market.

The IV catheter market benefits from continuous technological advancements aimed at improving safety, reducing complications, and enhancing user experience. Innovations include the development of catheters with features like antimicrobial coatings, safety needles, and ultrasound guidance systems, all of which contribute to the efficacy and safety of intravenous access. Manufacturers focus on designing IV catheters that reduce the risk of complications, such as infection, phlebitis, and infiltration. The integration of materials with improved biocompatibility, advanced tip designs, and antithrombotic coatings helps minimize the occurrence of adverse events associated with catheter insertion and use.

IV catheters are used in both routine and emergency care situations. Whether it's for administering routine medications, managing dehydration, or responding to life-threatening emergencies, IV catheters are a go-to tool for healthcare providers. This broad scope of application ensures their consistent demand in various healthcare settings.

Hospitals play a dominant role in the Intravenous (IV) equipment market for various reasons, reflecting their central position in providing healthcare services and the extensive use of IV therapy within hospital settings.

Hospitals serve as primary healthcare institutions where a significant volume of patient admissions occurs. The diverse healthcare needs of admitted patients often involve the administration of intravenous therapies, driving the demand for IV equipment. Intravenous therapy is a versatile and widely used mode of drug administration in hospitals. It allows for the rapid delivery of fluids, medications, and other therapeutic agents directly into the bloodstream. Hospitals routinely employ IV therapy for a wide range of conditions, including hydration, medication administration, blood transfusions, and critical care treatments.

Hospitals are equipped to handle emergencies and critical care situations, where the rapid administration of medications and fluids is essential. IV therapy is a critical component of emergency care and intensive care, and hospitals require a constant supply of IV equipment to address the diverse medical needs of patients in these settings.

Hospitals encompass various medical specialties, each with its unique requirements for intravenous therapy. From surgery to oncology, cardiology, and infectious diseases, IV therapy is utilized across multiple specialties. The diverse nature of hospital services contributes to the comprehensive demand for a variety of IV equipment. Hospitals often handle complex patient cases that require tailored treatment plans, including intravenous therapies. Patients with chronic illnesses, severe infections, and post-operative recovery needs may receive intravenous medications or fluids as part of their treatment regimen. Hospitals are equipped with the infrastructure and expertise to conduct specialized procedures that involve the use of IV equipment. This includes procedures such as intravenous catheter insertions, infusion pump applications, and the administration of specialized intravenous medications.

Research and teaching hospitals, which are prevalent in many regions, contribute significantly to the demand for IV equipment. These institutions are often at the forefront of medical innovation, clinical trials, and advanced treatments, requiring a continuous supply of state-of-the-art IV equipment.

The prevalence of the complexity of treatments, and the critical need for precise medication administration contribute to the dominance of cardiovascular applications in the IV equipment market.

Cardiovascular disorders, including heart disease, heart failure, and related conditions, are among the leading causes of morbidity and mortality globally. The widespread prevalence of these disorders results in a substantial patient population requiring intravenous therapies for diagnostic and treatment purposes. Cardiovascular emergencies often require rapid and precise intervention. Intravenous administration allows for the immediate delivery of medications to address critical conditions such as acute myocardial infarction, hypertensive emergencies, and arrhythmias. IV equipment, including infusion pumps and catheters, is essential for the timely administration of life-saving medications. Many medications used to manage cardiovascular disorders are administered intravenously to ensure rapid and effective delivery. IV therapy is commonly employed for anticoagulants, antiplatelet agents, inotropes, vasodilators, and other medications critical for treating cardiovascular conditions.

Patients with cardiovascular disorders often require continuous monitoring and adjustment of medications based on their clinical status. IV infusion pumps with advanced features allow healthcare providers to precisely control the rate of medication delivery, ensuring optimal therapeutic outcomes while minimizing the risk of adverse events. Hypertensive emergencies, characterized by severely elevated blood pressure requiring immediate intervention, often necessitate intravenous medications for rapid blood pressure control. IV equipment is crucial in these situations to administer antihypertensive medications and prevent further complications. Patients undergoing cardiovascular surgeries or procedures may require post-operative care, including intravenous medications for pain management, antiarrhythmics, and anticoagulants.

IV equipment is integral to the recovery process and the prevention of post-surgical complications. For individuals with chronic hypertension, long-term intravenous therapies may be required to manage blood pressure and prevent complications. IV equipment, such as ambulatory infusion pumps, allows patients to receive continuous medication infusion in outpatient settings.

Major Drivers

• Technological Advancements: Continuous technological innovations in the IV equipment industry drive the development of advanced devices and systems. Smart infusion pumps, needleless connectors, and improved catheter materials contribute to enhanced safety, precision, and patient outcomes. he integration of smart technologies improves the accuracy of infusion rates, reduces the risk of errors, and allows for remote monitoring, leading to improved patient care and healthcare efficiency.
• Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, contributes to the growing demand for intravenous therapies. IV equipment is essential for the administration of medications and fluids required for the management of chronic conditions. he expanding patient population with chronic diseases ensures a consistent need for IV equipment, driving market growth and encouraging further innovation in the development of specialized devices.

Major Challenges

• Infection Control and Complications: Infections related to IV catheters, as well as complications such as thrombosis and infiltration, pose significant challenges. Ensuring aseptic techniques during catheter insertion and minimizing complications are crucial for patient safety and reducing the economic burden associated with complications. fforts to address infection control and complications drive the development of innovative catheter designs, antimicrobial coatings, and safety measures, aiming to enhance the overall safety profile of IV equipment.
• Supply Chain Disruptions: The IV equipment industry is vulnerable to supply chain disruptions, including shortages of critical components and materials. Global events, economic factors, and logistical challenges can impact the production and distribution of IV equipment, affecting the ability to meet healthcare demands. stablishing resilient supply chain strategies, diversifying sourcing, and implementing contingency plans are essential to mitigate the impact of disruptions and ensure a steady supply of IV equipment to healthcare providers.

Major Trends

• Patient-Centric Design: There is a growing trend toward designing IV equipment with a focus on improving the patient experience. User-friendly interfaces, reduced noise levels, and portable devices enable patients to receive intravenous therapies comfortably, whether in a hospital setting or at home. Patient-centric design not only enhances patient satisfaction but also promotes adherence to treatment regimens, particularly for chronic conditions requiring long-term intravenous therapy.
• Integration of Data Analytics and Connectivity: The integration of data analytics and connectivity features in IV equipment allows for real-time monitoring, data collection, and analysis. This trend supports healthcare providers in making informed decisions, optimizing treatment plans, and improving overall patient care. Enhanced connectivity facilitates remote monitoring of infusion parameters, reduces the risk of errors, and contributes to more personalized and data-driven approaches to intravenous therapy.

COVID-19 Impact

The surge in COVID-19 cases led to an increased demand for IV equipment, especially in hospitals and healthcare facilities treating severe cases. Intravenous therapies were crucial for managing COVID-19 patients, particularly those requiring hydration, antiviral medications, and respiratory support. The pandemic has disrupted global supply chains, causing shortages and delays in the production and distribution of medical devices, including IV equipment. Lockdowns, travel restrictions, and increased demand strained the availability of essential components, contributing to challenges in maintaining a consistent supply.

With an emphasis on reducing hospital admissions and minimizing the risk of virus transmission, there was a notable shift towards telemedicine and home-based care. This trend increased the demand for portable and user-friendly IV equipment suitable for home infusion, impacting the product design and distribution strategies of manufacturers.

Many healthcare systems faced resource reallocation challenges during the pandemic, diverting attention and funds towards managing COVID-19 cases. This could have impacted the budgets allocated for purchasing new IV equipment and slowed down investment in certain areas of the industry. The disruption caused by the pandemic resulted in delays in product launches and clinical trials for new IV equipment. Travel restrictions, lockdowns, and prioritization of resources for pandemic-related activities hindered the usual timelines for bringing new innovations to market. In response to the heightened awareness of infection control, there was an increased emphasis on designing IV equipment with features to minimize the risk of contamination. Manufacturers focused on developing catheters with antimicrobial coatings and other safety measures to address concerns related to healthcare-associated infections.

Competitive Landscape

Major market players profiled in the report are Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC, Moog Inc., Terumo Corporation, Teleflex Incorporated, IRadimed Corporation, Amsino International, Inc., Cardinal Health, Inc., Codan US Corporation, Elcam Medical Inc, Hindustan Syringes & Medical Devices Ltd., Harsoria Healthcare Pvt Ltd, Nipro Corporation, Polymedicure, 3M, Vygon SAS and Zyno Medical, LLC etc.

Key Developments

• In August 2022, Lineus Medical's SafeBreak vascular received a Japanese utility patent, and the bifurcated venous access device (BVAD), a dual-lumen peripheral IV catheter, received a United States utility patent.
• In July 2022, B. Braun Medical Inc. launched its new Introcan Safety 2 IV Catheter with one-time blood control.
• In May 2019, B.Braun Medical announced that it intends to invest in the development of advanced IV infusion production facilities, which will make vital intravenous fluids safer and more productive when used by medical professionals on a regular basis.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global IV Equipment market with its value and forecast along with its segments
• Region & Country-wise IV Equipment market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions & Countries covered in the report

• North America (United States, Canada, Mexico)
• Europe (Germany, United Kingdom, France, Spain, Italy, Russia)
• Asia-Pacific (China, Japan, India, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle-East & Africa (UAE, Saudi Arabia, South Africa)

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the IV Equipment industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.